At the heart of gene edits in human embryos

Nerges Winblad and Fredrik Lanner ()
Additional contact information
Nerges Winblad: the Department of Clinical Science, Intervention and Technology, Karolinska Institutet
Fredrik Lanner: the Department of Clinical Science, Intervention and Technology, Karolinska Institutet

Nature, 2017, vol. 548, issue 7668, 398-400

Abstract: The gene-editing technology CRISPR–Cas has been used in human embryos grown in vitro to correct a disease-associated mutation. The introduction of editing components at fertilization aided repair efficiency. See Article p.413

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature23533 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:548:y:2017:i:7668:d:10.1038_nature23533

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature23533

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().